Log in to search using one of your social media accounts:

 

Magnitude of Anemia at Discharge Increases 30-Day Hospital Readmissions

Background: Anemia during hospitalization is associated with poor health outcomes. Does anemia at discharge place patients at risk for hospital readmission within 30 days of discharge? Our objectives were to examine the prevalence and magnitude of anemia at hospital discharge and determine whether anemia at discharge was associated with 30-day readmissions among a cohort of hospitalizations in a single health care system. Methods: From January 1, 2009, to August 31, 2011, there were 152,757 eligible hospitalizations within a single health care system. The endpoint was any hospitalization within 30 days of discharge. The University HealthSystem Consortium's clinical database was used for demographics and comorbidities; hemoglobin values are from the hospitals' electronic medical records, and readmission status was obtained from the University HealthSystem Consortium administrative data systems. Mild anemia was defined as hemoglobin of greater than 11 to less than 12 g/dl in women and greater than 11 to less than 13 g/dl in men; moderate, greater than 9 to less than or equal to 11 g/dl; and severe, less than or equal to 9 g/dl. Logistic regression was used to assess the association of anemia and 30-day readmissions adjusted for demographics, comorbidity, and hospitalization type. Results: Among 152,757 hospitalizations, 72% of patients were discharged with anemia: 31,903 (21%), mild; 52,971 (35%), moderate; and 25,522 (17%), severe. Discharge anemia was associated with severi...
Source: Journal of Patient Safety - Category: Health Management Tags: Original Articles Source Type: research

Related Links:

Publication date: February 2018 Source:Veterinary Immunology and Immunopathology, Volume 196 Author(s): Imke Hennink, Martin W. van Leeuwen, Louis C. Penning, Christine J. Piek Dogs suffering from canine idiopathic immune mediated hemolytic anemia (cIIMHA) are at great risk of dying particularly in the first two weeks after the diagnosis is made. This high mortality risk may be associated with the development of thromboembolism (TE) and/or disseminated intravascular coagulation (DIC) resulting in organ failure. The exact mechanism of the development of TE and/or DIC in cIIMHA is still undetermined. Therefore, this study i...
Source: Veterinary Immunology and Immunopathology - Category: Veterinary Research Source Type: research
Publication date: December 2017 Source:Comparative Immunology, Microbiology and Infectious Diseases, Volume 55 Author(s): Kaushlendra Singh, Harkirat Singh, Nirbhay Kumar Singh, Neeraj Kashyap, Naresh Kumar Sood, Shitanshu Shekar Rath Hepatozoonosis caused by Hepatozoon canis is an important tick-borne disease of dogs in tropical and sub-tropical regions throughout the world. In the present study evaluation of blood samples collected from 225 dogs presented at Small Animal Clinics, GADVASU, Ludhiana, Punjab (India) was done for the presence of H. canis by PCR based assay targeting a portion of 18S rRNA gene. Of the total ...
Source: Comparative Immunology, Microbiology and Infectious Diseases - Category: Infectious Diseases Source Type: research
Source: Annals of Hematology - Category: Hematology Source Type: research
LITFL • Life in the Fast Lane Medical Blog LITFL • Life in the Fast Lane Medical Blog - Emergency medicine and critical care medical education blog Just when you thought your brain could unwind on a Friday, you realise that it would rather be challenged with some good old fashioned medical trivia FFFF…introducing Funtabulously Frivolous Friday Five 218, all about colours. Question 1 What colour are you if you are suffering from ‘argryia’? + Reveal the Funtabulous Answer expand(document.getElementById('ddet1414906888'));expand(document.getElementById('ddetlink1414906888')) Purple or Purpl...
Source: Life in the Fast Lane - Category: Emergency Medicine Authors: Tags: Frivolous Friday Five amphotericin B argryia black lung blue bloater ciprofloxacin coal workers pneumoconiosis COPD emphysema infantile acrodynia mercury pink disease pink puffer Red man syndrome rifampicin silver skin teic Source Type: blogs
This study evaluated the correlation between retinopathy of prematurity (ROP), anaemia and blood transfusions in extremely preterm infants. MethodsWe included 227 infants born below 28 weeks of gestation at King Edward Memorial Hospital, Perth, Australia, from 2014–2016. Birth characteristics and risk factors for ROP were retrieved and anaemia and severe anaemia were defined as a haemoglobins of
Source: Acta Paediatrica - Category: Pediatrics Authors: Tags: Regular Article Source Type: research
Condition:   Thalassemia Interventions:   Drug: Colla corii asini;   Drug: a Simulate Agent of Colla corii asini granule Sponsor:   The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conclusion Scientific data obtained using modern scientific tools and evidence would support in utilizing the ancient Indian wisdom of Ayurveda for the development of newer drugs as a modern nanomedicine and in other possible technological applications.
Source: Journal of Ayurveda and Integrative Medicine - Category: Complementary Medicine Source Type: research
Conclusions— The 3-year amputation-free survival was not different between surgical reconstruction and EVT in the overall CLI population. The subsequent interaction analysis suggested that there would be a subgroup more suited for surgical reconstruction and another benefiting more from EVT. Clinical Trial Registration— URL: http://www.umin.ac.jp/ctr/. Unique identifier: UMIN000007050.
Source: Circulation: Cardiovascular Interventions - Category: Cardiology Authors: Tags: Peripheral Vascular Disease Source Type: research
ConclusionIn this heavily pretreated population including everolimus, fulvestrant plus palbociclib provides an mPFS of 5.8  months with the same magnitude of benefit for fulvestrant-pretreated patients.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
Anemia in myelofibrosis—prevalence, the U2AF1 connection, new treatmentsAnemia in myelofibrosis—prevalence, the U2AF1 connection, new treatments, Published online: 15 December 2017; doi:10.1038/s41408-017-0032-9Anemia in myelofibrosis—prevalence, the U2AF1 connection, new treatments
Source: Blood Cancer Journal - Category: Hematology Authors: Source Type: research
More News: Anemia | Databases & Libraries | Electronic Medical Records (EMR) | Health Management | Hospitals | Women